Molecular Pharmacology USA MLPH Stock
Molecular Pharmacology USA Price Chart
Molecular Pharmacology USA MLPH Financial and Trading Overview
| Molecular Pharmacology USA stock price | 0.02 USD |
| Previous Close | 0.02 USD |
| Open | 0.001 USD |
| Bid | 0.0008 USD x 42499900 |
| Ask | 0.006 USD x 2000000 |
| Day's Range | 0.0002 - 0.001 USD |
| 52 Week Range | 0.0002 - 0.49 USD |
| Volume | 125K USD |
| Avg. Volume | 65 USD |
| Market Cap | 403.82K USD |
| Beta (5Y Monthly) | -1.407 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MLPH Valuation Measures
| Enterprise Value | 2.1M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -21.37 |
Trading Information
Molecular Pharmacology USA Stock Price History
| Beta (5Y Monthly) | -1.407 |
| 52-Week Change | 304.00% |
| S&P500 52-Week Change | 20.36% |
| 52 Week High | 0.49 USD |
| 52 Week Low | 0.0002 USD |
| 50-Day Moving Average | 0.03 USD |
| 200-Day Moving Average | 0.04 USD |
MLPH Share Statistics
| Avg. Volume (3 month) | 65 USD |
| Avg. Daily Volume (10-Days) | 150 USD |
| Shares Outstanding | 19.99M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2014 |
| Most Recent Quarter (mrq) | September 30, 2014 |
| Next Fiscal Year End | June 30, 2015 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -569.41% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -98105 USD |
| Net Income Avi to Common (ttm) | -105181 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.52K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 2.08M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.276 |
| Book Value Per Share (mrq) | -0.019 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -109348 USD |
| Levered Free Cash Flow (ttm) | -65607 USD |
Profile of Molecular Pharmacology USA
| Country | United States |
| State | WA |
| City | Perth |
| Address | Drug Discovery Centre |
| ZIP | 6007 |
| Phone | 61 8 9443 3011 |
| Website | N/A |
| Industry | Shell Companies |
| Sector(s) | Financial Services |
| Full Time Employees | N/A |
Molecular Pharmacology (USA), Ltd., a development stage company, develops and commercializes pain and inflammation management products primarily in Australia, Europe, and the United States. The company, through its subsidiary, Molecular Pharmacology Pty. Ltd., develops Tripeptofen, an analgesic and anti-inflammatory molecule for the treatment of every-day pain. Its products are available in various dosage forms, formulations, line extensions, and package configurations. The company focuses on marketing its products through pharmaceutical distributors, and through collaborative dealings with companies. It also has an agreement with Dermatology Development Corporation to develop and market a range of therapeutic, cosmetic, and cosmeceutical products based on the ThermaLIFE product range and its active ingredients. The company is based in Perth, Australia. Molecular Pharmacology (USA), Ltd. is a subsidiary of PharmaNet Group Limited.
Q&A For Molecular Pharmacology USA Stock
What is a current MLPH stock price?
Molecular Pharmacology USA MLPH stock price today per share is 0.02 USD.
How to purchase Molecular Pharmacology USA stock?
You can buy MLPH shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Molecular Pharmacology USA?
The stock symbol or ticker of Molecular Pharmacology USA is MLPH.
Which industry does the Molecular Pharmacology USA company belong to?
The Molecular Pharmacology USA industry is Shell Companies.
How many shares does Molecular Pharmacology USA have in circulation?
The max supply of Molecular Pharmacology USA shares is 19.99M.
What is Molecular Pharmacology USA Price to Earnings Ratio (PE Ratio)?
Molecular Pharmacology USA PE Ratio is now.
What was Molecular Pharmacology USA earnings per share over the trailing 12 months (TTM)?
Molecular Pharmacology USA EPS is 0 USD over the trailing 12 months.
Which sector does the Molecular Pharmacology USA company belong to?
The Molecular Pharmacology USA sector is Financial Services.